Register Today for the 26th ASGCT Annual Meeting
Molecular Therapy Family Landscape Report
Get the latest on cell & gene therapy:
Claim MT Subscription
MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.
MTM focuses on advances in cell and gene therapy and how they are translated and applied in the clinical setting.
MTNA publishes top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease.
MTO focuses on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer.
The Landscape report, created in partnership with Informa Pharma Intelligence, is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
The Vector connects ASGCT Members with the latest news from the Society and the gene and cell therapy field. Issues are published on the second Thursday of each month.
Policy and advocacy professionals subscribe to The Advocate for the latest updates from ASGCT on regulatory policy, patient access, and other advocacy topics. Anyone interested can sign up for monthly emails.
The blog highlights ASGCT initiatives and events and provides insights on the state of gene and cell therapy industry.
Listen to luminaries in the worlds of cell and gene therapy. Subscribe to the channel wherever you get your podcasts.
May 16-20 | Los Angeles, CA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico